Advertisement
Canada markets closed
  • S&P/TSX

    21,642.87
    -97.33 (-0.45%)
     
  • S&P 500

    5,051.41
    -10.41 (-0.21%)
     
  • DOW

    37,798.97
    +63.86 (+0.17%)
     
  • CAD/USD

    0.7237
    -0.0017 (-0.23%)
     
  • CRUDE OIL

    85.30
    -0.11 (-0.13%)
     
  • Bitcoin CAD

    86,508.25
    -1,400.51 (-1.59%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,406.60
    +23.60 (+0.99%)
     
  • RUSSELL 2000

    1,970.47
    -5.23 (-0.26%)
     
  • 10-Yr Bond

    4.6590
    +0.0310 (+0.67%)
     
  • NASDAQ

    15,865.25
    -19.77 (-0.12%)
     
  • VOLATILITY

    18.14
    -1.09 (-5.67%)
     
  • FTSE

    7,820.36
    -145.17 (-1.82%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • CAD/EUR

    0.6811
    -0.0013 (-0.19%)
     

2 Stocks That Could Turn $100 Into $1,000 by 2028

2 Stocks That Could Turn $100 Into $1,000 by 2028

Doing so requires a substantial compound annual growth rate (CAGR) exceeding 58%. You're not likely to see such a rate among value stocks, which for all their consistency rarely grow at that pace. Two companies where I see that kind of progress over the next five years are Vir Biotechnology (NASDAQ: VIR) and Albemarle (NYSE: ALB).